Anavex Life Sciences (AVXL) Tops Q1 EPS by 2c

Anavex Life Sciences (NASDAQ: AVXL) reported Q1 EPS of ($0.17), $0.02 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on Anavex Life Sciences (AVXL) click here.

You May Also Be Interested In

• Cerebras CEO says investors misunderstood margin guidance
• TD Cowen cuts Flowserve to Hold, flags guidance reset risk amid Mideast woes
• CPI acquires TRISM instant issuance assets from HID Global